Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrika S H Simonsson

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|April 9, 2017
Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approachesRasmus Vestergaard Juul, Joakim Nyberg, Mads Kreilgaard, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2010
An example of optimal phase II design for exposure response modellingAlan Maloney, Marloes Schaddelee, Jan Freijer, et al.
European Journal of Clinical Pharmacology|May 11, 2006
Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patientsJustin J Wilkins, Grant Langdon, Helen McIlleron, et al.
Journal of Clinical Pharmacology|September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocationsHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
British Journal of Clinical Pharmacology|December 1, 2011
Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicinChao Zhang, Paolo Denti, Eric Decloedt, et al.
Anesthesiology|October 27, 2015
Repeated Time-to-event Analysis of Consecutive Analgesic Events in Postoperative PainRasmus Vestergaard Juul, Sten Rasmussen, Mads Kreilgaard, et al.
International Journal of Antimicrobial Agents|June 20, 2022
Pharmacometrics in tuberculosis: progress and opportunitiesJustin J Wilkins, Elin M Svensson, Jacqueline P Ernest, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis TreatmentLina Keutzer, Laurynas Mockeliunas, Marieke G G Sturkenboom, et al.
British Journal of Clinical Pharmacology|November 19, 2025
Population pharmacokinetics of TBAJ-587 and its main metabolites-Evaluation of different loading dose strategies and early dose selectionAlbin A M Leding, Paul Bruinenberg, Almari Conradie, et al.
The Journal of Antimicrobial Chemotherapy|November 15, 2017
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinationsOskar Clewe, Sebastian G Wicha, Corné P de Vogel, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Journal of Pharmacokinetics and Pharmacodynamics|April 9, 2017
Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approachesRasmus Vestergaard Juul, Joakim Nyberg, Mads Kreilgaard, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2010
An example of optimal phase II design for exposure response modellingAlan Maloney, Marloes Schaddelee, Jan Freijer, et al.
European Journal of Clinical Pharmacology|May 11, 2006
Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patientsJustin J Wilkins, Grant Langdon, Helen McIlleron, et al.
Journal of Clinical Pharmacology|September 4, 2007
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocationsHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
British Journal of Clinical Pharmacology|December 1, 2011
Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicinChao Zhang, Paolo Denti, Eric Decloedt, et al.
Anesthesiology|October 27, 2015
Repeated Time-to-event Analysis of Consecutive Analgesic Events in Postoperative PainRasmus Vestergaard Juul, Sten Rasmussen, Mads Kreilgaard, et al.
International Journal of Antimicrobial Agents|June 20, 2022
Pharmacometrics in tuberculosis: progress and opportunitiesJustin J Wilkins, Elin M Svensson, Jacqueline P Ernest, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis TreatmentLina Keutzer, Laurynas Mockeliunas, Marieke G G Sturkenboom, et al.
British Journal of Clinical Pharmacology|November 19, 2025
Population pharmacokinetics of TBAJ-587 and its main metabolites-Evaluation of different loading dose strategies and early dose selectionAlbin A M Leding, Paul Bruinenberg, Almari Conradie, et al.
The Journal of Antimicrobial Chemotherapy|November 15, 2017
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinationsOskar Clewe, Sebastian G Wicha, Corné P de Vogel, et al.
Pageof 11